Testing version — LOERadar is in active testing. Features and data may change.
GLYNASE (GLYBURIDE) | LOERadar
GLYNASE
NDA
GLYBURIDE | N020051 | PFIZER INC
4 strengths0 unique patents0 unique exclusivities
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
Para IV certification filed but no ANDA patent litigation cases (NOS 835) matched from PACER. Litigation may be pending or filed under a different caption.
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (4)
Sort:
#001 — 1.5MG
RLD
0 patents0 exclusivities▴
TABLET;ORAL | Approved: Mar 4, 1992
No patent or exclusivity listings for this strength.
#002 — 3MG
RLD
0 patents0 exclusivities▾
TABLET;ORAL | Approved: Mar 4, 1992
#003 — 4.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**